(19)
(11) EP 2 542 898 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
09.08.2017 Bulletin 2017/32

(45) Mention of the grant of the patent:
03.05.2017 Bulletin 2017/18

(21) Application number: 11700114.9

(22) Date of filing: 07.01.2011
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
G01N 33/74(2006.01)
 G01N 33/576(2006.01)
(86) International application number:
PCT/EP2011/000047
(87) International publication number:
WO 2011/083089 (14.07.2011 Gazette 2011/28)

(54)

PROGASTRIN AND LIVER PATHOLOGIES

PROGASTRIN UND LEBERERKRANKUNGEN

PROGASTRINE ET PATHOLOGIES HÉPATIQUES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 08.01.2010 US 293557 P

(43) Date of publication of application:
09.01.2013 Bulletin 2013/02

(73) Proprietor: Progastrine et Cancers S.à r.l.
1450 Luxembourg (LU)

(72) Inventors:
  • FLOCH, Jean-François
    F-34200 Sète (FR)
  • HOUHOU, Leïla
    F-34090 Montpellier (FR)

(74) Representative: Regimbeau 
La Coupole Sud 379, rue Léon Blum
34000 Montpellier
34000 Montpellier (FR)


(56) References cited: : 
US-A1- 2003 091 574
   
  • KONTUREK S J ET AL: "Progastrin and its products from patients with chronic viral hepatitis and liver cirrhosis.", SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, vol. 38, no. 6, June 2003 (2003-06), pages 643-647, XP009144698, ISSN: 0036-5521
  • KONTUREK STANISLAW J ET AL: "Plasma progastrin and leptin in type B and C viral hepatitis and liver cirrhosis", GASTROENTEROLOGY, vol. 122, no. 4 Suppl. 1, April 2002 (2002-04), pages A-306, XP002622810, & DIGESTIVE DISEASE WEEK AND THE 103RD ANNUAL MEETING OF THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION; SAN FRANCISCO, CA, USA; MAY 19-22, 2002 ISSN: 0016-5085
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).